Concord Biotech (BOM:543960) Pre-Tax Income : ₹4,126 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Concord Biotech's pretax income for the six months ended in Mar. 2024 was ₹2,318 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹4,126 Mil. Concord Biotech's pretax margin was 41.41%.

During the past 5 years, Concord Biotech's highest Pretax Margin was 51.77%. The lowest was 33.53%. And the median was 40.57%.

Concord Biotech Pre-Tax Income Historical Data

The historical data trend for Concord Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Pre-Tax Income Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

2,136.38

3,127.20

2,375.18

3,220.13

4,125.65

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial			-	938.63	2,281.50	1,807.41	2,318.24

Competitive Comparison of Concord Biotech's Pre-Tax Income

For the Biotechnology subindustry, Concord Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Biotech's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Concord Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Concord Biotech's Pre-Tax Income falls into.

Concord Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Concord Biotech's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	3779.656	+	0	+	-25.519	+	0	+	371.513
	=	4,126

Concord Biotech's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2129.615	+	0	+	-9.581	+	0	+	198.206
	=	2,318

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹4,126 Mil.

Concord Biotech (BOM:543960) Pre-Tax Income Explanation

Concord Biotech's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	2318.24	/	5597.659
	=	41.41%

During the past 5 years, Concord Biotech's highest Pretax Margin was 51.77%. The lowest was 33.53%. And the median was 40.57%.

Concord Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines